- Software company Corum Group (COO) has now officially completed the acquisition of PharmX and the PharmX Unit Trust
- Earlier this week, the company announced it was going to purchase the remaining 57 per cent interest in PharmX
- Corum will pay nearly $8 million in cash for the company and paid around $4 million on Friday
- The company is also undertaking an entitlement offer at 4.2 cents per share to raise around $5.6 million
- Funds raised will be used to partly fund the purchase of PharmX, working capital and offer and transaction costs
- On market close, Corum remains steady and is trading for five cents per share
